discovery of glp 1 History glucagon-like peptide-1 receptor agonists Understanding GLP-1 receptor agonists and

2022 Apr 5;15:10231030

Study tracks weight regain after stopping medication The new study, led by researchers at the University of Oxford and published in The BMJ, reviewed 37 existing clinical trials involving 9,341 participants who had taken weight-loss medications

If the side effects seem life threatening or if you think youre having a medical emergency, immediately call 911 or your local emergency number

Sources NIH: GLP-1 and energy balance: an integrated model of short-term and long-term control SingleCare: Does Ozempic make you tired

After supply disruptions for semaglutide and tirzepatide ended, facilities continued producing glucagon-like peptide-1 receptor agonists (GLP-1 RAs) using compounded formulations that include added ingredients, according to a study published in JAMA Health Forum (doi:10.1001/jamahealthforum.2026.2207)

However, the clinical implications of these findings remain under investigation